Ill be honest I didnt expect much
As the prevalence of these metabolic disorders continues to rise, the GLP-1 receptor agonist market is set for substantial growth in the coming years
When the FDA removes semaglutide from the shortage list (expected late 2026), compounding pharmacies must stop production regardless of patent status
In an interview in 1976, Albert Hofmann, who discovered LSD, said small doses of psychedelics could improve mood and help with depression
What's more, a study in the journal Molecular Psychiatry reveals GLP-1 sends hunger-taming signals to the hypothalamus , the brain region that's been dubbed the "master regulator" of satiety
The Clinical Trial Results (Prepare to Be Impressed) Retatrutide is currently in Phase 3 trials, but the Phase 2 results published in the New England Journal of Medicine have people talking